Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsThe field of veterinary medicine is undergoing a revolution, with monoclonal antibodies (mAbs) emerging as a cornerstone for treating a spectrum of complex canine diseases, from atopic dermatitis to cancer. A non-canine antibody, however effective in its original species, is often recognized as foreign by a dog's immune system, leading to reduced efficacy and potential adverse events. With over 20 years of pioneering experience in antibody engineering, Creative Biolabs have perfected the science of antibody caninization. Our sophisticated platform transforms your lead monoclonal antibody—whether murine, human, or otherwise—into a highly effective and minimally immunogenic therapeutic, ready to advance canine health. Partner with us to unlock the full potential of your veterinary biologics pipeline.
The therapeutic success of a monoclonal antibody is intrinsically linked to its ability to operate stealthily within the host's body. When an antibody from a different species (a xenogeneic antibody) is introduced into a dog, the canine immune system can mount a potent defense.
This response, resulting in the formation of Canine Anti-Drug Antibodies (CADA), poses significant risks to therapeutic development:
Antibody caninization is the definitive solution to overcoming immunogenicity. This sophisticated bioengineering process meticulously redesigns a non-canine antibody to appear "canine" to the dog's immune system, thereby avoiding rejection.
The process involves grafting the essential antigen-binding loops—the Complementarity-Determining Regions (CDRs)—from your high-performing parent antibody onto a carefully selected canine antibody framework. The result is a chimeric molecule that retains the precise target specificity of your original antibody while gaining the immune tolerance of a native canine protein.
Key Benefits of Our Caninization Service:
At Creative Biolabs, antibody caninization is not a one-size-fits-all process. Our platform integrates computational design with empirical validation to guarantee a superior outcome.
The journey begins with a comprehensive analysis of your parent antibody. We sequence the variable domains and utilize advanced in silico 3D modeling to create a high-resolution structural map. This allows us to identify the critical residues within the CDRs responsible for antigen binding and the key framework residues that support the CDRs' canonical structure.
Choosing the right acceptor framework is paramount for low immunogenicity. We don't use generic templates. Instead, we screen our extensive database of canine germline sequences to select a framework that exhibits the highest sequence homology to your parent antibody. This "best-fit" approach provides a superior foundation for retaining function and minimizing foreign epitopes.
With the optimal canine framework selected, our experts perform the precision CDR grafting. Using advanced molecular biology techniques, we seamlessly transfer the six CDRs from your parent antibody into the new canine framework, effectively transplanting the antibody's "targeting system."
Directly grafting CDRs can sometimes lead to a loss of affinity due to subtle conformational changes. This is where our expertise truly shines. Our computational platform analyzes the 3D model of the newly grafted antibody to identify any framework residues in the canine acceptor that may sterically or electrostatically interfere with the CDR loops. We then rationally design and introduce a minimal set of "back-mutations"—reverting specific framework residues to their original murine counterparts—to restore the ideal CDR conformation and preserve high-affinity binding.
To ensure we deliver the absolute best candidate, we often construct a small, focused library of caninized variants based on our computational designs. This library is expressed on the surface of phage or yeast and screened against the target antigen. This powerful empirical screening method allows us to isolate the caninized antibody with the most optimal combination of high affinity, stability, and production yield, moving you forward with a truly elite therapeutic candidate.
In a competitive landscape, your choice of a service partner is critical. Creative Biolabs offers an unrivaled combination of experience, technology, and a client-centric philosophy.
Creative Biolabs is your strategic partner for the entire antibody therapeutic development lifecycle. Our antibody caninization service integrates perfectly with our other world-class offerings.
Don't let immunogenicity be a barrier to success. Partner with the world's leading experts in antibody engineering to develop safer, more effective monoclonal antibody therapies for canines.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
